These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 3925729

  • 1. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A, Gutiérrez Sanz-Gadea C, Hernández Fernández C, Mateos Torres A, Maganto Pavón E, Mayayo Dehesa T.
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of superficial carcinoma of the bladder.
    Paulson DF.
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract] [Full Text] [Related]

  • 3. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 4. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
    Kurth KH, Debruyne FJ, Senge T, Carpentier PJ, Riedl H, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1985; 185B():135-42. PubMed ID: 3898138
    [No Abstract] [Full Text] [Related]

  • 6. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 7. Treatment of bladder cancer with intravesical instillation of adriamycin.
    Pavone-Macaluso M, Ingargiola GB, Tripi M, Lamartina M.
    Prog Clin Biol Res; 1984; 162B():181-91. PubMed ID: 6390445
    [Abstract] [Full Text] [Related]

  • 8. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.
    Fisher HA.
    Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The management of superficial bladder cancer.
    Soloway MS.
    Cancer; 1980 Apr 15; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract] [Full Text] [Related]

  • 12. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?
    Soloway MS, Arianayagam M.
    Urology; 2010 Oct 15; 76(4):794-6. PubMed ID: 20932403
    [No Abstract] [Full Text] [Related]

  • 13. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.
    J Urol; 2007 Aug 15; 178(2):451-4. PubMed ID: 17561135
    [Abstract] [Full Text] [Related]

  • 14. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar 15; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 15. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP.
    Semin Urol Oncol; 1996 Feb 15; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL, Ojea A, Jamardo D, Figueiredo L.
    Actas Urol Esp; 1984 Feb 15; 8(4):325-8. PubMed ID: 6435407
    [No Abstract] [Full Text] [Related]

  • 17. [Results and long-term course of superficial bladder carcinomas treated with local adriamycin. Apropos of 69 cases].
    Iborra I, Mazcuñán F, Monros JL, Ricos JV, Solsona E.
    Arch Esp Urol; 1987 Sep 15; 40(7):455-60. PubMed ID: 3688987
    [No Abstract] [Full Text] [Related]

  • 18. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder.
    Kaufman DS, Shipley WU, McDougal WS, Young RH.
    N Engl J Med; 2004 Jan 22; 350(4):394-402. PubMed ID: 14736932
    [No Abstract] [Full Text] [Related]

  • 19. The role of surgery in initial staging and follow up.
    Herr HW.
    Prog Clin Biol Res; 1990 Jan 22; 353():35-43. PubMed ID: 2217425
    [No Abstract] [Full Text] [Related]

  • 20. Intravesical chemotherapy. Treatment selection, techniques, and results.
    Richie JP.
    Urol Clin North Am; 1992 Aug 22; 19(3):521-7. PubMed ID: 1636236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.